<DOC>
	<DOCNO>NCT00004039</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop cancer cell divide stop grow die . Combining interferon alfa monoclonal antibody rituximab chemotherapy may kill cancer cell . PURPOSE : Phase II trial compare effectiveness combination chemotherapy plus interferon alfa rituximab treat patient high risk stage III stage IV lymphoma .</brief_summary>
	<brief_title>Combination Chemotherapy Plus Interferon Alfa Rituximab Treating Patients With Stage III Stage IV Lymphoma</brief_title>
	<detailed_description>OBJECTIVES : I . Determine toxicity cyclophosphamide , doxorubicin , vincristine , prednisone ( CHOP ) either interferon alfa rituximab patient stage III IV high risk indolent intermediate B-cell lymphoma . II . Determine objective tumor response rate duration response regimens patient . III . Determine failure free survival overall survival patient regimens . IV . Compare response rate survival rate patient regimens similar patient treat publish study . V. Compare toxicity regimens patient . VI . Determine quality life patient regimens . OUTLINE : This multicenter study . Patients assign one two treatment arm : Arm I : Patients receive rituximab IV day 0 , cyclophosphamide IV , doxorubicin IV , vincristine IV day 1 , follow oral prednisone day 1-5 . Arm II : Patients receive interferon alfa subcutaneously day 22-26 , cyclophosphamide IV , doxorubicin IV , vincristine IV day 1 , follow oral prednisone day 1-5 . Treatment repeat every 28 day 8 course absence disease progression unacceptable toxicity . Quality life assess baseline prior chemotherapy course . Patients follow every 3 month 2 year , every 6 month 2 year , annually 10 year . PROJECTED ACCRUAL : A total 40-80 patient ( 20-40 per treatment arm ) accrue study .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm high risk ( stage III IV ) indolent intermediate ( stage II IV ) Bcell lymphoma Small cleave cell lymphoma Waldenstrom 's macroglobulinemia Follicular small cleave cell mixed cell Follicular large cell Diffuse Immunoblastic High risk define : Increased LDH OR Increased beta2microglobulin OR B symptom OR Bulky disease great 7 cm diameter OR Extranodal disease blood bone marrow involvement OR Mantle zone histology At least 1 lymph node visceral lesion least 2 cm diameter PATIENT CHARACTERISTICS : Age : Not specify Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No active infection medical condition lifethreatening Not pregnant Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : No prior therapy lymphoma</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Waldenstrom macroglobulinemia</keyword>
	<keyword>stage II grade 3 follicular lymphoma</keyword>
	<keyword>stage II adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage II adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage II adult diffuse large cell lymphoma</keyword>
	<keyword>stage II adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage II adult Burkitt lymphoma</keyword>
	<keyword>stage III grade 1 follicular lymphoma</keyword>
	<keyword>stage III grade 2 follicular lymphoma</keyword>
	<keyword>stage III grade 3 follicular lymphoma</keyword>
	<keyword>stage III adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage III adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage III adult diffuse large cell lymphoma</keyword>
	<keyword>stage III adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage III adult Burkitt lymphoma</keyword>
	<keyword>stage IV grade 1 follicular lymphoma</keyword>
	<keyword>stage IV grade 2 follicular lymphoma</keyword>
	<keyword>stage IV grade 3 follicular lymphoma</keyword>
	<keyword>stage IV adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage IV adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage IV adult diffuse large cell lymphoma</keyword>
	<keyword>stage IV adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage IV adult Burkitt lymphoma</keyword>
	<keyword>stage III mantle cell lymphoma</keyword>
	<keyword>stage IV mantle cell lymphoma</keyword>
</DOC>